A researcher is creating a new treatment protocol for Myelodysplastic Syndrome (MDS), a form of preleukemia. Following the old treatment protocol, 28% of patients with MDS will develop leukemia within 5 years of MDS diagnosis. He believes his new treatment protocol will lead to fewer MDS patients developing leukemia. He takes a random sample of 100 individuals on his new treatment protocol. Of these 100 individuals, 20 develop leukemia within 5 years of MDS diagnosis. Conduct a hypothesis test at the 10% level to test this claim that his new treatment protocol will lead to fewer MDS patients developing leukemia. What is the correct decision? a. Fail to Reject the Null Hypothesis b. Accept the Null Hypothesis c. Reject the Null Hypothesis d. Accept the Alternative Hypothesis
A researcher is creating a new treatment protocol for Myelodysplastic Syndrome (MDS), a form of preleukemia. Following the old treatment protocol, 28% of patients with MDS will develop leukemia within 5 years of MDS diagnosis. He believes his new treatment protocol will lead to fewer MDS patients developing leukemia. He takes a random sample of 100 individuals on his new treatment protocol. Of these 100 individuals, 20 develop leukemia within 5 years of MDS diagnosis.
Conduct a hypothesis test at the 10% level to test this claim that his new treatment protocol will lead to fewer MDS patients developing leukemia.
What is the correct decision?
| a. |
Fail to Reject the Null Hypothesis |
|
| b. |
Accept the Null Hypothesis |
|
| c. |
Reject the Null Hypothesis |
|
| d. |
Accept the Alternative Hypothesis |
Trending now
This is a popular solution!
Step by step
Solved in 2 steps with 3 images
